FDA Investigator Anthony A Charity
Anthony A Charity has inspections in 13 countries as of 27 Sep 2023. Anthony A Charity has collaborated with a combinined 4011 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
48
Last Inspection Date:
27 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
China,
France,
Italy,
Mexico,
United Kingdom of Great Britain and Northern Ireland,
Australia,
Netherlands,
South Africa,
India,
Spain,
Germany
Co-Investigator(s):
Amy N Chen,
Ana P Pineda Zavaleta,
Anastasia M Shields,
Anissa M Vargas,
Anita R Michael,
Ann Marie Karnick,
Anne M Pilaro,
Anne Marie Karnick,
Anthony C Warchut,
Arie C Menachem,
Arnold Seo, PhD,
Arsen Karapetyan,
Atul J Agrawal,
Audrey Thereset Uy,
Azza Talaat,
Barbara J Rincon,
Bonita S Chester,
Brian D Young,
Cara M Minelli,
CDR Ileana Barreto Pettit,
Charanjeet Jassal,
Charles M Edwards,
Charles R Cote, RIC,
Cheryl A Clausen,
Chiang Syin, PhD,
Colleen M Damon,
Constantin Y Philopoulos,
Craig D Zagata,
Daniel P Becker,
Daniel R Tammariello,
Darren S Brown,
David A Oluwo,
David J Hafner,
Debra J Bennett,
Debra L Pagano,
Denise M Digiulio,
Dennis Cantellops Paite,
Dipesh K Shah,
Donald L Lech,
Douglas A Campbell,
Dr. Gerald E Poly,
Dr. Mark J Seaton, PhD,
Edward D Mcdonald,
Edwin Martinez,
Edwin Melendez,
Elena Karnaukhova, PhD,
Eric M Mueller, PharmD,
Erika V Butler,
Farhana Khan,
Frank W Perrella,
Gayle S Lawson,
George Pyramides,
Geraldine D Sanders,
Gess,
Gwyn G Dickinson,
H Ljamilla Selby,
Hala L Selby,
Hala Lj Whetstone,
Hamet Toure, PharmD MPH,
Heriberto Negron Rivera,
Jai P Singh,
James D Planchon,
James M Mason,
James P Mcevoy,
Javier E Santos,
Jeen S Min,
Joanne M Schlossin,
Joel D Hustedt,
John D White,
Jonathan W Chapman,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Jose R Hernandez,
Joseph Brady,
Joseph L Despins, PhD,
Joseph T Dougherty,
Joshua P Wireman,
Juanita P Versace,
Julianne C Mccullough,
Junho Pak,
Junho Park,
Justin A Boyd,
Kara D Dobbin,
Karen Takahashi,
Karl D Hezel,
Karthik B Iyer,
Karyn M Campbell,
Katherine Szestypalow,
Kelly N Kerr,
Kendra L Brooks,
Kenneth M Gordon,
Kent C Faul,
Kevin A Gonzalez,
Kevin P Foley,
Kham Phommachanh,
Kim Lthomas Cruse,
Kimberley A Hoefen,
Ko U Min,
Kristen D Evans,
Kristina J Donohue,
Kristina Mjoyce Pittman,
Kristy A Zielny,
Laurie B Frazier,
Laurie Nelson,
Laurimer Kuilan Torres,
LCDR Debra Emerson,
LCDR Susan E Polifko,
Lisa Shie,
Lisa Shin,
Lloyd D Payne,
Lourdes Valentin Aponte,
Lucas B Leake,
Luis A Carrion,
Luis A Dasta,
Luis M Burgos Medero,
Madushini Dharmasena, PhD,
Marc A Jackson, Jr,
Margaret M Annes,
Maria A Reed,
Marianela Aponte Cruz,
Marie F Morin,
Marisol Faberlle,
Marvin D Jones,
Mary Ddavis Lopez,
Mary E Storch,
Massoud Motamed,
Matthew B Casale,
Matthew R Noonan,
Meisha R Sampson,
Meisha Waters,
Michael A Charles,
Michael A Taylor,
Michael C Rogers,
Michael F Skelly, PhD,
Michael Gurbarg,
Michael P Sheehan,
Michael R Goga,
Michele L Obert,
Michele M Falchek,
Michele Perry Williams,
Mike M Rashti,
Mra Mcculloughj,
Nancy G Schmidt,
Nicholas A Violand,
Nicholas L Hunt,
Nicole E Knowlton,
Nicole K Trudel,
Niketa Patel,
Nikhil Thakur,
Nikisha M Bolden,
Patricia H Dlugosz,
Patrick L Wisor,
Paul L Bellamy,
Paul Mouris,
Peter E Baker,
Phillip Angart, PhD,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Rabin N Ghoshal,
Rafael Nevarez Nieves,
Rakhi B Shah,
Ralph H Vocque,
Raquel Gonzalez Rivera,
Reba A Gates,
Reyes Candau Chacon, PhD,
Richard Heath Coats,
Robert B Shibuya, MD,
Robert C Coleman,
Robert J Maffei,
Robin P Mathew,
Rochelle K Kimmel,
Rochelle L Cross,
Roger F Zabinski,
Rose Ljean Mary,
Rozelle G Smith,
Saied A Asbagh,
Saleem A Akhtar,
Sam Pepe,
Samuel T Walker,
Sandra A Hughes,
Santiago Gallardo Johnson,
Sarah E Mcmullen,
Sarah K Graham,
Satheesh Thomas,
Shirley J Berryman,
Simone E Pitts,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Stephen J Koniers,
Steven B Hertz,
Steven C Madzo,
Steven D Kehoe,
Steven E Kane,
Steven M Weinman,
Steven P Donald,
Susan F Laska, MS,
Susan M Jackson,
Susan W Ting,
Susanna E Ford, Analyst,
Susant Hadman,
Tamil Arasu, PhD,
Tammy L Chavis,
Tara G Bizjak,
Tara R Gooen,
Ted L Anderson,
Tekalign Wondimu,
Temar Q Williams,
Teresa I Navas,
Terri L Dodds,
Thomas E Friel,
Thomas J Arista,
Tiffani D Wilson,
Truong Xuan Nguyen (Andy),
Van Cliff,
Vlada Matusovsky,
Wayne T Smith,
William J Leonard,
Yumi J Hiramine,
Yvette I Henry,
Yvette I Johnson,
Yvonne C Mcknight,
Yvonne C Wood,
Zachary A Bogorad,
Zedong Dong,
Zhongren Wu
Anthony A Charity's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more